PTH and Hypocalcemia: In practice, we intend to utilise an initial cinacalcet dose of 30 mg/day in most patients, except those with baseline PTH > 30 pmol/L, with a view to reduce drug acquisition costs and possibly reducing the incidence of hypocalcaemia, without diminishing the effect on Ca.